跳至主要内容
临床试验/NL-OMON43477
NL-OMON43477招募中不适用

Iodine Mapping using Subtraction in Pulmonary Embolism Computed Tomography versus Dual Energy Computed Tomography. - InSPECT vs DECT

Radboud Universitair Medisch Centrum0 个研究点目标入组 375 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
375

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • - patients 35 years or older and able to provide informed consent
  • - clinically requested CTPA because of suspected pulmonary embolism
  • - available history and physical examination

排除标准

  • - pregnancy
  • - hemodynamic instability
  • - uncooperative patients
  • - contra-indication to intravenous iodine administration.
  • - inability to position the arms above the shoulders

研究者

相似试验

已完成
不适用
Pulmonary Perfusion by Iodine Subtraction Mapping CT Angiography in Acute Pulmonary EmbolismPulmonary Embolism
NCT03579849University Hospital, Brest30
已完成
不适用
Confirmation of pulmonary intersegment with indocyanine greelung malignant tumor
JPRN-UMIN000027877Kansai Medical University Medical Center200
进行中(未招募)
1 期
Identification of the thoracic duct using a vital dye in patients undergoing minimally invasive esophagectomyChylothorax is a serioso post-operative complication, which occurs in 2-12% of patients undergoing esophagectomy. Thoracic duct lesion leads to a reduction of body fluids and albumin resulting in hypovolemia, also delays oral food intake, increase hospital stay and negatively affects overall survival. It is also associated with pneuomonia resulting in difficulty breathing, which also determines an increased risk of sepsis.MedDRA version: 20.0Level: PTClassification code 10051228Term: ChylothoraxSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disorders
EUCTR2019-004374-25-ITAZIENDA OSPEDALIERO-UNIVERSITARIA UDINE49
已完成
不适用
Iodine seed (I-125) as a marker in lung-lesionsintrathoracaal (en intraparenchymaal) gelegen longafwijkingen (benigne en maligne)Unidentified lung-lesion10027655
NL-OMON35843Amphia Ziekenhuis10
进行中(未招募)
1 期
identification of the thoracic duct using a vital dye in patient undergoing esophagectomyChylothorax is a serious post-operative complication, with occurs in 2-12% of patients undergoing esophagectomy. Thoracic duct lesion leads to a reduction of body fluids and albumin resulting in hypovolemia, also delays oral food intake, increase hospital stay and negatively affects overall survival. It is also associated with pneumonia resulting in difficulty breathing, which also determines an increased risk of sepsis.MedDRA version: 20.0Level: PTClassification code 10051228Term: ChylothoraxSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disorders
EUCTR2020-003974-33-ITAZIENDA OSPEDALIERO-UNIVERSITARIA UDINE100